Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析

◆英語タイトル:Selecta Biosciences Inc (SELB) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14791
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (SVP) technology platform to incorporate a wide range of antigens and immunomodulators, for the development of products that induce antigen-specific tolerance or activate the immune system. Selecta Biosciences develops products for the treatment of infections, central nervous system diseases, cancer, allergies, cardiovascular diseases, autoimmunity, metabolic diseases, asthma and acute and chronic inflammatory conditions. The company collaborates with pharma companies to develop drugs for allergy and autoimmune diseases. Selecta Biosciences is headquartered in Watertown, Massachusetts, the US.

Selecta Biosciences Inc Key Recent Developments

Jan 03,2019: Selecta Biosciences expands potential for ImmTOR platform and streamlined structure under leadership of new CEO, Carsten Brunn, Ph.D.
Jan 03,2019: Selecta Biosciences to reduce 36% of workforce
Nov 08,2018: Selecta Biosciences announces third quarter 2018 financial results and provides corporate update
Nov 06,2018: Selecta Biosciences to Present at the Stifel Healthcare Conference 2018
Nov 01,2018: Selecta Biosciences to Report Third Quarter 2018 Financial Results and Update on SEL-212 Development Strategy, including Planned Head-to-Head Study versus Krystexxa

This comprehensive SWOT profile of Selecta Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Selecta Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Selecta Biosciences Inc – Key Information
Selecta Biosciences Inc – Overview
Selecta Biosciences Inc – Key Employees
Selecta Biosciences Inc – Key Employee Biographies
Selecta Biosciences Inc – Key Operational Heads
Selecta Biosciences Inc – Major Products and Services
Selecta Biosciences Inc – History
Selecta Biosciences Inc – Company Statement
Selecta Biosciences Inc – Locations And Subsidiaries
Selecta Biosciences Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Selecta Biosciences Inc – Business Description
Selecta Biosciences Inc – Corporate Strategy
Selecta Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Selecta Biosciences Inc – Strengths
Selecta Biosciences Inc – Weaknesses
Selecta Biosciences Inc – Opportunities
Selecta Biosciences Inc – Threats
Selecta Biosciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Selecta Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Selecta Biosciences Inc, Key Information
Selecta Biosciences Inc, Key Ratios
Selecta Biosciences Inc, Share Data
Selecta Biosciences Inc, Major Products and Services
Selecta Biosciences Inc, History
Selecta Biosciences Inc, Key Employees
Selecta Biosciences Inc, Key Employee Biographies
Selecta Biosciences Inc, Key Operational Heads
Selecta Biosciences Inc, Other Locations
Selecta Biosciences Inc, Subsidiaries
Selecta Biosciences Inc, Key Manufacturing facilities
Selecta Biosciences Inc, Key Competitors
Selecta Biosciences Inc, SWOT Analysis
Selecta Biosciences Inc, Ratios based on current share price
Selecta Biosciences Inc, Annual Ratios
Selecta Biosciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Selecta Biosciences Inc, Performance Chart
Selecta Biosciences Inc, Ratio Charts

★海外企業調査レポート[Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • British American Tobacco Bangladesh:企業の戦略・SWOT・財務情報
    British American Tobacco Bangladesh - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco Bangladesh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Wenzel Downhole Tools Ltd:企業の戦略的SWOT分析
    Wenzel Downhole Tools Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Georgia Power Co (GPW):電力:M&Aディール及び事業提携情報
    Summary Georgia Power Co (Georgia Power), a subsidiary of the Southern Power Company, generates, transmits, distributes and sells electricity. The company produces electricity using various sources of energy such as coal, nuclear, solar, gas and hydro. It supplies electricity in Georgia and to whole …
  • Manulife Holdings Berhad:企業の戦略・SWOT・財務情報
    Manulife Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Manulife Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Vita 34 AG (V3V):製薬・医療:M&Aディール及び事業提携情報
    Summary Vita 34 AG (Vita 34), formerly Vita 34 International AG, is an umbilical cord blood bank that collects, prepares, processes, deposits, and stores stem cells from umbilical cord blood. The company's products comprise vitaplus, vitaplus25, vitaplus50, vitapluscordtissue, vitapluscordtissue25, …
  • Oneness Biotech Co Ltd (4743):製薬・医療:M&Aディール及び事業提携情報
    Summary Oneness Biotech Co Ltd (Oneness Biotech) is a biopharmaceutical company that conducts research and development of drugs. The company provides products such as anti acne products. Its technologies comprise GAP cultivation platform, medicinal material identification, and separation and purific …
  • Continental AG:企業のM&A・事業提携・投資動向
    Continental AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Continental AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Innovation Pharmaceuticals Inc (IPIX)-製薬・医療分野:企業M&A・提携分析
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp is a biopharmaceutical company that offers discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company offers kevetrin for t …
  • Nachi-Fujikoshi Corp.:企業の戦略・SWOT・財務分析
    Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report Summary Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Salk Institute for Biological Studies-製薬・医療分野:企業M&A・提携分析
    Summary Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise molecular biology and genetics, neurosciences, and plant biology. Its research provides development of new therapies and treatments for di …
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), a subsidiary of Aarti Group of Industries is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and special …
  • NeuroMetrix Inc (NURO):企業の財務・戦略的SWOT分析
    Summary NeuroMetrix Inc (NeuroMetrix) is a healthcare company company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, quell health cloud, DPNCheck point-of- …
  • China Aviation Oil (Singapore) Corp Ltd (G92):企業の財務・戦略的SWOT分析
    China Aviation Oil (Singapore) Corp Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Kancera AB (KAN):企業の財務・戦略的SWOT分析
    Summary Kancera AB (Kancera) is a developer of drug candidates for the treatment of cancer. The company’s pipeline products include fractalkine inhibitor AZD8797, used to stop tumor growth; small molecule HDAC6 inhibitors, for neutralizing blood cancer; small molecule PFKFB3 inhibitors, for stopping …
  • IncellDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary IncellDx Inc (IncellDx) is a single cell diagnostic company that develops transformative diagnostic and prognostic clinical patient information technologies. The company detects and monitors life threatening viral diseases in the areas of cervical cancer, HIV and AIDS, hepatitis, and organ t …
  • Robins & Morton LLC:企業の戦略・SWOT・財務情報
    Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report Summary Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Blood Cell Storage Inc:医療機器:M&Aディール及び事業提携情報
    Summary Blood Cell Storage Inc (BCSI) is a medical device company that discovers and develops bio-medical technology products. The company’s products comprise IVF safe sens, platelets ph safe, and nucleic acid extraction systems, among others. Its IVF safe sens comprise trackstation and in-vessel mo …
  • Marubeni Corp (8002):企業の財務・戦略的SWOT分析
    Marubeni Corp (8002) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Evonik Industries AG:企業のM&A・事業提携・投資動向
    Evonik Industries AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evonik Industries AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Impinj Inc (PI):企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆